Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - AbbVie Inc. | abbv-20171231xex322.htm |
| EX-32.1 - EXHIBIT 32.1 - AbbVie Inc. | abbv-20171231xex321.htm |
| EX-31.2 - EXHIBIT 31.2 - AbbVie Inc. | abbv-20171231xex312.htm |
| EX-31.1 - EXHIBIT 31.1 - AbbVie Inc. | abbv-20171231xex311.htm |
| EX-23 - EXHIBIT 23 - AbbVie Inc. | abbv-20171231xex23.htm |
| EX-21 - EXHIBIT 21 - AbbVie Inc. | abbv-20171231xex21.htm |
| EX-12.2 - EXHIBIT 12.2 - AbbVie Inc. | abbv-20171231xex122.htm |
| EX-10.26 - EXHIBIT 10.26 - AbbVie Inc. | abbv-20171231xex1026.htm |
| EX-10.25 - EXHIBIT 10.25 - AbbVie Inc. | abbv-20171231xex1025.htm |
| 10-K - 10-K - AbbVie Inc. | abbv-20171231x10k.htm |
Exhibit 12.1
AbbVie Inc.
Ratio of Earnings to Fixed Charges
(unaudited)
The following table sets forth AbbVie’s historical ratios of earnings to fixed charges for the periods indicated. This information should be read in conjunction with the financial statements and accompanying notes included under Item 8, “Financial Statements and Supplementary Data” and Item 7, “Management's Discussion and Analysis of Financial Condition and Results of Operations.” For further information, see Exhibit 12.2 entitled “Computation of Ratio of Earnings to Fixed Charges”.
2017 | 2016 | 2015 | 2014 | 2013 | |||||||
Ratio of earnings to fixed charges | 7.3 | 7.4 | 8.0 | 6.0 | 16.6 | ||||||